Skip to content
La Clinique du Sommeil
La Clinique du Sommeil
All news
Clinical study

A study on the efficacy and safety of vornorexant for insomnia

A study examined the efficacy and safety of vornorexant, a medication for treating insomnia, over a 52-week period in Japanese patients. The results show an improvement in sleep and good tolerance of the treatment.

A study on the efficacy and safety of vornorexant for insomnia

What is vornorexant?

Vornorexant is a medication that acts on orexin receptors, a chemical involved in the regulation of sleep. It is used to treat insomnia, a disorder that makes it difficult to fall asleep or stay asleep.

The results of the study

This study followed Japanese patients suffering from insomnia for 52 weeks. The results show that vornorexant led to a significant reduction in the time needed to fall asleep and an improvement in sleep quality. The most common side effects were upper respiratory infections and drowsiness, but no serious adverse effects were reported.

What this means for patients

For individuals suffering from insomnia, this study suggests that vornorexant could be an effective and well-tolerated treatment option in the long term. However, it is important to discuss with a healthcare professional to evaluate treatment options suitable for each situation.

This article is provided for information only and does not replace medical advice. For any question about your own situation, talk to your doctor.